 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/314800
An Exploration of Consolidation in the Generics Industry
|
Description: |
The generics industry worldwide is undergoing an unprecedented period of consolidation. This trend began in the United States during the early and mid 1990s, but the focus turned to Europe and India in the late 1990s and continues into the early part of the 21st century. After the initial flurry of activity in the United States in the early 1990s, U.S. generics companies have shown little recent activity in terms of acquisitions, but elsewhere both the pace and scale of this consolidation have accelerated since 2000.
In this report, we examine the wave of M&As taking place across the generics sector and explore the reasons behind this consolidation, such as the competitive pressures in operation, the need for greater mass, and the use of acquisitions to facilitate market entry. We consider the implications of consolidation for the U.S. generics industry and other developed markets as the generics industry becomes more international in character and discuss the future of the generics industry and its likely impact on the branded pharmaceutical industry.
|
|
Contents: |
Overview The Generics Market at a Glance Factors Driving Industry Consolidation Cost Pressures Need for Greater Size and Economies of Scale Entry into New Geographic Markets Gaining Access to New Therapeutic Areas and New Technologies Generics Industry M&A Activity in Review Generics Industry Leaders Follow an Aggressive Acquisition Strategy U.S. Companies Remain Focused on the Domestic Market Indian Companies of All Sizes Seek Entry into Overseas Markets Outlook List of Tables and Figures Figure 1. U.S. Patent Expiries for the Top 40 Best Selling Drugs, 2005-2021 Figure 2. Impact of Consolidation on Market Share in the German Generics Market, 1999-2004 Table 1. Select Generics Company Acquisitions, 2000-2005 Table 2. Leading Generics Companies by Sales, 2004 Table 3. Select Teva Acquisitions, 1980-2005 Table 4. Select Sandoz/Novartis Acquisitions, 1963-2005 Table 5. Select Merck KGaA Acquisitions, 1994-2005
|
|
Companies Mentioned |
Companies mentioned in this report include:
- Abic
- Able Laboratories
- Actavis
- Alpharm France
- Amarin Development
- Amide Pharmaceutical
- Amifarma
- Apotek
- APS/Berk
- Barr Laboratories
- BASF Generics
- Bayer Basics
- Bayer Classics
- Bayer Self-Medication
- Biogal
- Biotechna
- Copley Pharmaceutical
- CP Pharmaceuticals
- Dorom
- Duramed Pharmaceuticals
- Durascan
- Endeavour Pharmaceuticals
- Eon Labs
- Esparma
- Galena
- GlaxoSmithKline
- Glenmark Pharmaceuticals
- GRY-Pharma
- Heumann Pharma
- Hexal
- Hikal
- Human Serum & Pharmceutical Manufacturing
- Ikapharm
- Ivax
- Johnson & Johnson
- Kali Laboratories
- Katwijk Farma
- Laboratorios Klinger
- Lagap
- Lek PharmaTech
- Lemmon
- Makoff R&D Laboratories
- Marsing
- Merck KGaA
- Migada
- Netpharm Scandanavia
- NM Pharma
- Novartis
- Novopharm
- Par Pharmaceutical
- Pfizer
- Pharbil
- Pharmchemie
- Polfa Kutno
- Prasfarma
- Prosintex
- Ranbaxy
- Ratiopharm
- RPG Aventis
- Sabex
- Sandoz
- Sandoz-Hexal-Azupharma
- Schein Pharmaceutical
- Sicor
- Stada
- Teva
- Torrent Pharmaceuticals
- Tutag
- Watson Pharmaceuticals
- Wockhardt
- Zydus Cadila
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/314800
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 05/09/2008 21:55:33 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
An Exploration of Consolidation in the Generics Industry
|
|
Web Address: |
http://www.researchandmarkets.com/reports/314800
|
|
Office Code: |
|
OCHHGMNKPWY
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Single User
|
|
€695.00
|
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
 |
Page 2 of 2 Printed 05/09/2008 21:55:33
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder Name: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
|
 |
 |
|
|